American Labs

Impax Laboratories has merged with Amneal Pharmaceuticals, operating under the umbrella of the combined entity since May 4, 2018. Amneal Pharmaceuticals Inc. is publicly traded on the New York Stock Exchange under the ticker AMRX. As part of this merger, Amneal Pharmaceuticals provides a range of products, which includes those from Impax and Gemini Laboratories. The company is committed to addressing product quality and safety standards within the pharmaceutical industry. Generated from the website

Gemini Laboratories, a subsidiary of Amneal Pharmaceuticals based in Bridgewater, NJ, is committed to creating essential medicines and advancing healthcare through a diverse portfolio of approximately 280 generic and specialty pharmaceuticals. The company prioritizes innovation and accessibility, developing first-to-file and first-to-market complex medicines while supporting patients and communities in navigating conditions such as Parkinson's disease. With a strong focus on patient care, Gemini Laboratories actively contributes to public health initiatives, including increasing access to critical medications like Naloxone Nasal Spray. Their culture emphasizes collaboration and dedication, driving efforts to make healthy possible for patients and their families. Generated from the website

We provide a unique and effective approach to Contract Laboratory and Analytical Testing services that focuses on partnering with you, our client - serving as an extension of your analytical, discovery, R&D, manufacturing and quality team. As your partner in science, we understand what's important